Natal Bioproducts Institute

Natal Bioproducts Institute (NBI) is a South African-based biotechnology company specializing in the manufacture of plasma-derived medicinal products and antivenoms. As a leading producer in the Southern African region, NBI processes human plasma to create essential therapies such as albumin, coagulation factors, and immunoglobulins. The institute is also globally recognized for its production of high-quality polyvalent and monovalent antivenoms used to treat envenomation from various venomous snakes and spiders. NBI operates a GMP-compliant manufacturing facility and plays a critical role in the public health infrastructure of South Africa and neighboring countries.